| 摘要 |
Compounds of this invention are non-peptide, reversible inhibitors of type (2) methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
|
| 申请人 |
SMITHKLINE BEECHAM CORPORATION;MARINO, JOSEPH, P., JR.;THOMPSON, SCOTT, K.;VEBER, DANIEL, F. |
发明人 |
MARINO, JOSEPH, P., JR.;THOMPSON, SCOTT, K.;VEBER, DANIEL, F. |
